159 related articles for article (PubMed ID: 31476444)
1. Global plasma protein profiling reveals DCM characteristic protein signatures.
Feig MA; Pop C; Bhardwaj G; Sappa PK; Dörr M; Ameling S; Weitmann K; Nauck M; Lehnert K; Beug D; Kühl U; Schultheiss HP; Völker U; Felix SB; Hammer E
J Proteomics; 2019 Oct; 209():103508. PubMed ID: 31476444
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies.
Hammer E; Goritzka M; Ameling S; Darm K; Steil L; Klingel K; Trimpert C; Herda LR; Dörr M; Kroemer HK; Kandolf R; Staudt A; Felix SB; Völker U
J Proteome Res; 2011 May; 10(5):2161-71. PubMed ID: 21417265
[TBL] [Abstract][Full Text] [Related]
3. Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy.
Bhardwaj G; Dörr M; Sappa PK; Ameling S; Dhople V; Steil L; Klingel K; Empen K; Beug D; Völker U; Felix SB; Hammer E
J Proteomics; 2017 Jan; 150():121-129. PubMed ID: 27616206
[TBL] [Abstract][Full Text] [Related]
4. In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy.
Liu S; Xia Y; Liu X; Wang Y; Chen Z; Xie J; Qian J; Shen H; Yang P
Oncotarget; 2017 Jul; 8(29):48321-48332. PubMed ID: 28427148
[TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase activity in patients with ischaemic and nonischaemic dilated cardiomyopathy.
Gungoren F; Senturk T; Ozturk A; Koz K; Sarandol E; Yesilbursa D; Gullulu S; Ozkaya G; Aydinlar A
Acta Cardiol; 2018 Feb; 73(1):85-90. PubMed ID: 28899213
[TBL] [Abstract][Full Text] [Related]
6. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy.
Calderon-Dominguez M; Belmonte T; Quezada-Feijoo M; Ramos M; Calderon-Dominguez J; Campuzano O; Mangas A; Toro R
Sci Rep; 2021 Apr; 11(1):7517. PubMed ID: 33824379
[TBL] [Abstract][Full Text] [Related]
7. Fat deposition in dilated cardiomyopathy assessed by CMR.
Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
[TBL] [Abstract][Full Text] [Related]
8. Heart failure biomarkers in patients with dilated cardiomyopathy.
Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
[TBL] [Abstract][Full Text] [Related]
9. Is hyperhomocysteinemia a causal factor for heart failure? The impact of the functional variants of MTHFR and PON1 on ischemic and non-ischemic etiology.
Strauss E; Supinski W; Radziemski A; Oszkinis G; Pawlak AL; Gluszek J
Int J Cardiol; 2017 Feb; 228():37-44. PubMed ID: 27863359
[TBL] [Abstract][Full Text] [Related]
10. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
[TBL] [Abstract][Full Text] [Related]
12. Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy.
Colak D; Alaiya AA; Kaya N; Muiya NP; AlHarazi O; Shinwari Z; Andres E; Dzimiri N
PLoS One; 2016; 11(10):e0162669. PubMed ID: 27711126
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy.
Mehra S; Kumar M; Manchanda M; Singh R; Thakur B; Rani N; Arava S; Narang R; Arya DS; Chauhan SS
Mol Cell Biochem; 2017 Apr; 428(1-2):139-147. PubMed ID: 28074340
[TBL] [Abstract][Full Text] [Related]
14. Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy.
Mathier MA; Rose GA; Fifer MA; Miyamoto MI; Dinsmore RE; Castaño HH; Dec GW; Palacios IF; Semigran MJ
J Am Coll Cardiol; 1998 Jul; 32(1):216-24. PubMed ID: 9669273
[TBL] [Abstract][Full Text] [Related]
15. Dilated cardiomyopathy with re-worsening left ventricular ejection fraction.
Nabeta T; Inomata T; Ishii S; Yazaki M; Fujita T; Iida Y; Ikeda Y; Maekawa E; Naruke T; Koitabashi T; Ako J
Heart Vessels; 2019 Jan; 34(1):95-103. PubMed ID: 29942977
[TBL] [Abstract][Full Text] [Related]
16. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Okizaki A; Yamamoto W; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
Ann Nucl Med; 2003 Oct; 17(7):541-8. PubMed ID: 14651352
[TBL] [Abstract][Full Text] [Related]
17. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
18. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.
Pankuweit S; Lüers C; Richter A; Ruppert V; Gelbrich G; Maisch B;
Eur J Clin Invest; 2015 Sep; 45(9):906-17. PubMed ID: 26094644
[TBL] [Abstract][Full Text] [Related]
19. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Wang X; Asai S; Tsuji T; Tanaka H; Saito Y; Kuwahara K; Nakao K; Kinoshita M
J Am Coll Cardiol; 2001 Nov; 38(5):1485-90. PubMed ID: 11691527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
